| IV-34 Mira Tout Rituximab target-mediated elimination is influenced by both baseline antigenic burden and FCGR3A polymorphism in chronic lymphocytic leukemia Thursday 14:40-16:00 |
| IV-34 Mira Tout Rituximab target-mediated elimination is influenced by both baseline antigenic burden and FCGR3A polymorphism in chronic lymphocytic leukemia Thursday 14:40-16:00 |